Ocular Therapeutix Inc. (OCUL)
5.89
-1.25 (-17.51%)
At close: Mar 03, 2025, 3:59 PM
5.93
0.59%
After-hours: Mar 03, 2025, 04:16 PM EST
Ocular Therapeutix Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -4.41 | -3.41 | -49.28 | -7.88 | -1.99 | -2.63 | -2.02 | -4.65 | -5.48 | -8.75 | -2.92 | -2.76 |
| PEG Ratio | -0.14 | -0.01 | 0.52 | -0.24 | -0.06 | 0.08 | -0.09 | -0.88 | 0.15 | 0.22 | 0.53 | n/a |
| PS Ratio | 6.09 | 4.20 | 12.23 | 72.26 | 42.31 | 76.23 | 66.69 | 110.08 | 124.46 | 324.55 | n/a | 3.88K |
| PB Ratio | 3.91 | 6.11 | 6.05 | 16.53 | -49.26 | 4.23 | 4.90 | 3.99 | 2.43 | 4.27 | -0.65 | -0.83 |
| P/FCF Ratio | -4.66 | -3.41 | -7.98 | -23.12 | -2.24 | -2.97 | -2.18 | -5.78 | -6.13 | -11.52 | -2.98 | -3.04 |
| P/OCF Ratio | -5.07 | -3.62 | -8.12 | -23.48 | -2.31 | -3.08 | -2.54 | -6.11 | -6.45 | -12.22 | -3.07 | -3.09 |
| OCF/S Ratio | -1.2 | -1.16 | -1.51 | -3.08 | -18.35 | -24.74 | -26.25 | -18.02 | -19.28 | -26.55 | n/a | -1.26K |
| Debt / Equity Ratio | 0.92 | 1.82 | 0.67 | 0.77 | -16.35 | 0.69 | 0.69 | 0.30 | 0.17 | 0.25 | -0.04 | -0.09 |
| Quick Ratio | 6.59 | 4.07 | 7.22 | 9.19 | 4.92 | 6.11 | 3.22 | 8.41 | 19.87 | 12.95 | 5.39 | 6.98 |
| Current Ratio | 6.66 | 4.13 | 7.26 | 9.23 | 5.00 | 6.14 | 3.23 | 8.42 | 19.89 | 12.97 | 5.39 | 6.98 |
| Asset Turnover | 0.23 | 0.34 | 0.21 | 0.07 | 0.05 | 0.03 | 0.03 | 0.03 | 0.02 | 0.01 | n/a | 0.00 |
| Interest Coverage | -7.27 | -11.2 | -11.7 | -9.29 | -14.06 | -34 | -32.73 | -25.79 | -22.16 | -24.21 | -29.26 | -36.26 |
| Return on Equity (ROE) | -0.89 | -1.79 | -0.12 | -2.1 | 24.78 | -1.61 | -2.42 | -0.86 | -0.44 | -0.49 | 0.22 | 0.30 |
| Return on Assets (ROA) | -0.32 | -0.42 | -0.05 | -0.61 | -1.14 | -0.79 | -1.14 | -0.6 | -0.36 | -0.37 | -0.7 | -0.56 |
| Return on Capital (ROIC) | -0.38 | -0.67 | -0.44 | -0.27 | -1.29 | -0.93 | -1.47 | -0.65 | -0.36 | -0.37 | -0.82 | -0.63 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 90.96% | 91.18% | 89.88% | 88.03% | 45.00% | 76.63% | 76.24% | 76.52% | 81.77% | 88.21% | n/a | 30.00% |
| Net Profit Margin | -138.14% | -123.16% | -24.82% | -917.26% | -2.13K% | -2.9K% | -3.3K% | -2.37K% | -2.27K% | -3.71K% | n/a | -140.93K% |
| Pretax Profit Margin | -138.14% | -137.95% | -15.06% | -894.31% | -2.04K% | -3.01K% | -3.3K% | -2.37K% | -2.27K% | -3.71K% | n/a | -140.93K% |
| Operating Profit Margin | -140.96% | -152.74% | -179.3% | -361.13% | -2.03K% | -2.97K% | -3.22K% | -2.3K% | -2.18K% | -3.51K% | n/a | -136.71K% |
| FCF Margin | -130.59% | -122.96% | -153.36% | -312.56% | -1.89K% | -2.57K% | -3.05K% | -1.9K% | -2.03K% | -2.82K% | n/a | -127.88K% |
| EBITDA Margin | -113.64% | -120.22% | -173.74% | -839.48% | -1.84K% | -2.81K% | -3.11K% | -2.23K% | -2.13K% | -3.5K% | n/a | -133.12K% |